Search

everythinglearnresearchcommunity

for

Search:↓

Erosive pustular dermatosis of the scalp is a type of skin inflammation often confused with other conditions, requiring continuous treatment.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Lupus can cause hair loss and nail changes, with treatments available for both.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

CBG may help with various medical conditions but needs more human research to confirm safety and effectiveness.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Adding diltiazem to a beta blocker can cause dangerously slow heart rates.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Collecting hair for cortisol analysis is possible in low-income mother-toddler pairs.

Psychotropic medications can cause skin problems but also treat some skin conditions.

Hair loss is common in IBD patients, and some medications may lower the risk.